Karimikia Ehsan, Behravan Javad, Zarghi Afshin, Ghandadi Morteza, Omid Malayeri Sina, Ghodsi Razieh
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Iran J Basic Med Sci. 2019 Oct;22(10):1138-1146. doi: 10.22038/ijbms.2019.34760.8242.
In this study a series of novel colchicine-like β-acetamidoketones was designed and synthesized as potential tubulin inhibitors.
The cytotoxicity of the novel synthesized β-acetamidoketones was assessed against two cancerous cell lines including MCF-7 (human breast cancer cells) and A549 (adenocarcinomic human alveolar basal epithelial cells) employing the MTT test. Tubulin polymerization test was done by using a commercial kit (tubulin polymerization assay kit).
In general, the cytotoxicity activities were highly dependent on the aromatic substitution pattern of phenyl ring at β position of β-acetamidoketones. Based upon, compound possessing the same structural elements of colchicine and chalcone 1, revealed the most cytotoxicity more than the other β-acetamidoketone against the cancerous cell lines and showed moderate antitubulin effect. The tubulin inhibitory effect of , colchicine and chalcone 1 were consistent with their antiproliferative activities. Molecular docking studies of , into the colchicine-binding site of tubulin exhibited possible mode of interaction between this compound and tubulin.
The structure activity relationship (SAR) data attained showed that the presence of trimethoxy phenyl attached to carbonyl group of β-acetamidoketones and a methoxy group at position of the other ring are essential for cytotoxic activity. In general, the cytotoxicity activities were highly dependent on the aromatic substitution pattern of phenyl ring at β position of β-acetamidoketones.
在本研究中,设计并合成了一系列新型秋水仙碱样β-乙酰氨基酮,作为潜在的微管蛋白抑制剂。
采用MTT试验评估新合成的β-乙酰氨基酮对两种癌细胞系的细胞毒性,这两种癌细胞系包括MCF-7(人乳腺癌细胞)和A549(人肺泡基底上皮腺癌细胞)。使用商业试剂盒(微管蛋白聚合检测试剂盒)进行微管蛋白聚合试验。
一般来说,细胞毒性活性高度依赖于β-乙酰氨基酮β位苯环的芳香取代模式。基于此,具有秋水仙碱和查耳酮1相同结构元素的化合物,对癌细胞系显示出比其他β-乙酰氨基酮更强的细胞毒性,并表现出中等的抗微管蛋白作用。该化合物、秋水仙碱和查耳酮1的微管蛋白抑制作用与其抗增殖活性一致。该化合物与微管蛋白秋水仙碱结合位点的分子对接研究展示了该化合物与微管蛋白之间可能的相互作用模式。
所获得的构效关系(SAR)数据表明,连接到β-乙酰氨基酮羰基上的三甲氧基苯基以及另一环α位上的甲氧基的存在对细胞毒性活性至关重要。一般来说,细胞毒性活性高度依赖于β-乙酰氨基酮β位苯环的芳香取代模式。